 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR...

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

ThermoGenesis Holdings, Inc. (NASDAQ:THMO  Get Free Report) saw a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 5,700...

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Short Interest Down 55.1% in August

ThermoGenesis Holdings, Inc. (NASDAQ:THMO  Free Report)  HC Wainwright lowered their Q1 2024 earnings estimates for ThermoGenesis in a note issued to investors on Friday, August 11th. HC Wainwright analyst S. Lee now forecasts that the company will post earnings per share of $0.01 for ...

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Expected to Earn Q1 2024 Earnings of $0.01 Per Share

ThermoGenesis Holdings, Inc. (NASDAQ:THMO Free Report) Equities research analysts at HC Wainwright lowered their Q1 2024 EPS estimates for ThermoGenesis in a report released on Friday, August 11th. HC Wainwright analyst S. Lee now anticipates that the company will earn $0.01 per share for the ...

Research Analysts Offer Predictions for ThermoGenesis Holdings, Inc.'s Q1 2024 Earnings (NASDAQ:THMO)

H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on ThermoGenesis Holdings (THMO Research Report) today and set a price target of $5.... H.C. Wainwright analyst Sean Lee CFA maintained a Buy rating on ThermoGenesis Holdings (THMO  Res...

H.C. Wainwright Reaffirms Their Buy Rating on ThermoGenesis Holdings (THMO)

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate...

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu PR Newswire RANCHO CORDOVA, Calif., July 17, 2023 RANCHO CORDOVA, Calif., July 17, 2023 /PRNewswire...

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

ThermoGenesis Holdings, Inc. (NASDAQ:THMO Get Rating) saw a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 38,900 shares, an increase of 27.1% from the May 15th total of 30,600 shares. Approximately 2.5% of the shares of the stock are ...

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Sees Significant Increase in Short Interest

ThermoGenesis Holdings, Inc. (NASDAQ:THMO  Get Rating)  Equities researchers at HC Wainwright dropped their FY2023 earnings per share estimates for ThermoGenesis in a research report issued to clients and investors on Tuesday, May 16th. HC Wainwright analyst S. Lee now forecasts that ...

FY2023 Earnings Estimate for ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Issued By HC Wainwright

ThermoGenesis Holdings, Inc. (NASDAQ:THMO Get Rating) Equities researchers at HC Wainwright dropped their FY2023 earnings per share estimates for ThermoGenesis in a research report issued to clients and investors on Tuesday, May 16th. HC Wainwright analyst S. Lee now forecasts that the company will ...

ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.

Watchers	14,622
52-Wk Low	$1.03
52-Wk High	$14.40

Market Cap	$2.98M
Volume (M)	2,370.00
52-Wk High	$14.40
52-Wk Low	$1.03

THMO ThermoGenesis Holdings Inc

About

Feed

News

Sentiment

Earnings

Fundamentals